Tevogen Bio
TVGN6.72013.13% ( +0.780 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Tevogen Bio(TVGN) the EBIT is -5.401 M (+47.85%);the EPS is -1.61 (+50.45%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B47.85%
----
----
EPS
-1.612450.45%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf